Incidence and Risk Factors for Thalidomide Neuropathy: a Prospective Study of 135 Dermatologic Patients
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 119 (5) , 1020-1026
- https://doi.org/10.1046/j.1523-1747.2002.19502.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- THALIDOMIDEDermatologic Clinics, 2001
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.Annals of the Rheumatic Diseases, 1994
- Guideline for the clinical use and dispensing of thalidomidePublished by Oxford University Press (OUP) ,1994
- Thalidomide for the Treatment of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1992
- Thalidomide neuropathy: An electrophysiologic studyMuscle & Nerve, 1986
- Development of polyneuropathy during thalidomide therapyBritish Journal of Dermatology, 1985
- Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosusBritish Journal of Dermatology, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958